DB12684InvestigationalProtein Based Therapies
Cy 503 is under investigation in clinical trial NCT00658437 (Aviscumine for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy).
- Code names
- CY503
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of February 21, 2021
Which companies are running trials of Aviscumine, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account